The board of directors of China Resources Pharmaceutical Group Limited announced, with effect from 5 July 2019 Mr. LI Guohui has resigned as an executive director, the chief financial officer, vice president, a member of the executive committee and corporate governance committee and an authorized representative of the Company due to personal career development. WENG Jingwen has been appointed as an executive director, the chief financial officer, vice president, a member of the executive committee and corporate governance committee and an authorized representative of the company. WENG Jingwen has 12 years of experience in financial management and auditing and 8 years of experience in strategic development and business analysis.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.15 HKD | -0.65% | -1.28% | +20.08% |
May. 16 | China Resources Sanjiu, China Resources Power to Continue Cooperating on New Energy Projects | MT |
Apr. 24 | China Resources Pharmaceutical Group Limited Announces Change of Company Secretary | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.08% | 4.98B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 3320 Stock
- News China Resources Pharmaceutical Group Limited
- China Resources Pharmaceutical Group Limited Announces Management Changes